Understanding feeling "high" and its role in medical cannabis patient outcomes.
Frontiers in Pharmacology May 24, 2023 DOI: 10.3389/fphar.2023.1135453 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Peer reviewed |
|---|---|
| Topics | Cannabis |
| Key points | The abstract indicates that the study will examine the role of feeling "high" in medical cannabis patient outcomes, but no findings are reported. |
Abstract
Understanding feeling "high" and its role in medical cannabis patient outcomes.
Citations in the library
Cited by 4
- Sociodemographic differences and experienced effects of young adults who use cannabis mainly for self-medication versus recreationally in Finland Drugs, Habits and Social Policy August 18, 2023
- Learning how to make use of dissociative therapies. International Review of Psychiatry December 1, 2024
- Cannabis and cannabinoids for the treatment of mental and substance use disorders and symptoms: A systematic review and meta-analysis of experimental and observational studies. Psychiatry Research August 1, 2026
- The holistic effects of medical cannabis compared to opioids on pain experience in Finnish patients with chronic pain. Journal of Cannabis Research November 9, 2023
Cites 3
- Systematic combinations of major cannabinoid and terpene contents in Cannabis flower and patient outcomes: a proof-of-concept assessment of the Vigil Index of Cannabis Chemovars Journal of Cannabis Research February 8, 2023
- Acute effects of high-potency cannabis flower and cannabis concentrates on everyday life memory and decision making. Scientific Reports July 2, 2021
- The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin. British Journal of Pharmacology January 2008